{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "OVB.L",
  "generated_at": "2026-02-10T23:27:08.556186Z",
  "top_card": {
    "ticker": "OVB.L",
    "company_name": "Ovoca Bio plc",
    "sector": "Healthcare",
    "market_cap_gbp": 5294430,
    "days_active": 395,
    "apex_score_100": 58,
    "confidence_score_100": 25,
    "ai_final_score_25": 17,
    "ai_strength": "STRONG",
    "timing_regime": "BROKEN",
    "action": "AVOID",
    "thesis_one_liner": "AVOID - BROKEN timing with 58/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Ovoca Bio plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 5294430,
      "current_close_price": 10.5
    },
    "basics": {
      "ticker": "OVB.L",
      "current_price": 10.5,
      "ath": 26.0,
      "atl": 0.0115,
      "ath_date": "2022-02-23",
      "atl_date": "2025-05-08",
      "week_52_high": 11.0,
      "week_52_low": 0.0115,
      "week_52_high_date": "2026-02-09",
      "week_52_low_date": "2025-05-08",
      "drawdown_from_ath_pct": 59.62,
      "data_start": "2020-01-02",
      "data_end": "2026-02-09",
      "total_bars": 1337
    },
    "latest_signal": {
      "date": "2025-01-10",
      "scan_date": "2026-01-26",
      "signal_type": "ULTRA CRASH BOTTOM",
      "signal_color": "RED",
      "price": 0.016,
      "drawdown_pct": 99.19,
      "ai_score": 14.0,
      "rsi": 0.0,
      "cycle_position": 0.0005,
      "holding_period_days": 395,
      "current_pnl_pct": 65525.0,
      "rally_state": "accumulating",
      "distance_from_high_pct": -99.28,
      "Rally_Count": 1,
      "days_since_last_high": 270,
      "last_high_date": "2025-05-01",
      "lock_in_reached": true,
      "lock_in_date": "2025-01-13",
      "best_rally_pct": 9900.0
    },
    "best_historical_signal": {
      "signal_date": "2022-12-13",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "entry_price": 4.75,
      "peak_price": 14.8,
      "peak_date": "2023-08-29",
      "rally_pct": 211.58,
      "days_to_peak": 259,
      "ai_score": 11.0
    },
    "all_historical_signals": [
      {
        "signal_id": "OVB.L_2022-12-13",
        "signal_date": "2022-12-13",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 1140,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2022-12-14",
        "signal_date": "2022-12-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 1139,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-08-31",
        "signal_date": "2023-08-31",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.75,
        "current_price": 0.0115,
        "current_return_pct": -99.58,
        "best_rally_pct": -12.73,
        "best_rally_date": "2023-09-01",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 879,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-01",
        "signal_date": "2023-09-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.4,
        "current_price": 0.0115,
        "current_return_pct": -99.52,
        "best_rally_pct": -6.25,
        "best_rally_date": "2023-09-04",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 878,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-06",
        "signal_date": "2023-09-06",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.25,
        "current_price": 0.0115,
        "current_return_pct": -99.49,
        "best_rally_pct": -4.44,
        "best_rally_date": "2023-09-07",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 873,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-05",
        "signal_date": "2023-10-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.4,
        "current_price": 0.0115,
        "current_return_pct": -99.18,
        "best_rally_pct": 37.14,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 844,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-06",
        "signal_date": "2023-10-06",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 0.0115,
        "current_return_pct": -99.22,
        "best_rally_pct": 30.17,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 843,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-10",
        "signal_date": "2023-10-10",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 839,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-13",
        "signal_date": "2023-10-13",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 836,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-11-29",
        "signal_date": "2023-11-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.25,
        "current_price": 0.0115,
        "current_return_pct": -99.08,
        "best_rally_pct": 53.6,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 789,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-01",
        "signal_date": "2023-12-01",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 787,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-05",
        "signal_date": "2023-12-05",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 783,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-07",
        "signal_date": "2023-12-07",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.0115,
        "current_return_pct": -98.9,
        "best_rally_pct": 82.86,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 781,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-21",
        "signal_date": "2023-12-21",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 767,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-22",
        "signal_date": "2023-12-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 766,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-27",
        "signal_date": "2023-12-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 761,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-01-04",
        "signal_date": "2024-01-04",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.825,
        "current_price": 0.0115,
        "current_return_pct": -98.61,
        "best_rally_pct": 132.73,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 753,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-02-29",
        "signal_date": "2024-02-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.8,
        "current_price": 0.0115,
        "current_return_pct": -98.56,
        "best_rally_pct": 140.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 697,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-03-26",
        "signal_date": "2024-03-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.7,
        "current_price": 0.0115,
        "current_return_pct": -98.36,
        "best_rally_pct": 174.29,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 671,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-02",
        "signal_date": "2024-04-02",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 664,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-03",
        "signal_date": "2024-04-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 663,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-07-01",
        "signal_date": "2024-07-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.775,
        "current_price": 0.0115,
        "current_return_pct": -98.52,
        "best_rally_pct": 147.74,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 574,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-08-28",
        "signal_date": "2024-08-28",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.725,
        "current_price": 0.0115,
        "current_return_pct": -98.41,
        "best_rally_pct": 164.83,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 516,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2025-01-10",
        "signal_date": "2025-01-10",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.016,
        "current_price": 0.0115,
        "current_return_pct": -28.12,
        "best_rally_pct": 9900.0,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.28,
        "days_since_last_high": 270,
        "lock_in_reached": true,
        "age_days": 381,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 24,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 3747.27,
      "median_rally_pct": 902.07,
      "best_rally_pct": 68650.0,
      "worst_rally_pct": 211.58
    },
    "splits": [
      {
        "date": "2025-05-08",
        "ratio": "1:20",
        "ratio_value": 100.0
      }
    ],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "HAS_REVERSE_SPLIT",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-10 20:44:18 UTC",
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "ACCUMULATION"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 58/100 indicates strong opportunity quality",
      "Timing regime: BROKEN",
      "Historical profile: 1 rallies, 9900% best run"
    ],
    "main_risk": "Confidence 25/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "OVB.L",
      "latest": [
        {
          "title": "Change of Name",
          "announcement_date": "5th Feb 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "5 Feb 2026 07:00\nRNS Number : 7831R\nOvoca Bio PLC\n05 February 2026\nOvoca Bio Plc (to be renamed Talisman Metals PLC)\n(\"Talisman\" or the \"Company\")\nName and TIDM Change\nDublin, Ireland, 5 February 2026 - Talisman announces it has now received approval from the Companies Registration Office for its name change to Talisman Metals PLC after a shareholder vote on 27 January 2026 approving such change. As such, on 6 February 2026 it is expected that trading in the name Talisman Metals PLC on AIM with the TIDM 'TLM' will become effective.\nEnd\nFor further information:\nTalisman Metals PLC\nTim McCutcheon (Chief Executive Officer)\nTel +353 (0) 1 525 6710\ncontactus@talismanmetalsplc.com\nBeaumont Cornish Limited (Nominated Adviser)\nJames Biddle / Roland Cornish\nTel: +44 (0) 207 628 3396\nCMC Markets UK Plc (Broker)\nThomas Smith / Thomas Curran\nTel: +44 (0) 20 3003 8255\nBlytheRay (Financial PR)\nMegan Ray / Said Izagaren\nTel: +44 207 138 3204\ntalismanmetals@blytheray.com\nNominated Adviser Statement\nBeaumont Cornish Limited (\"Beaumont Cornish\"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nCANFZGGZLDKGVZM",
          "rns_number": "RNS Number : 7831R"
        },
        {
          "title": "Readmission - Ovoca Bio PLC",
          "announcement_date": "28th Jan 2026",
          "release_time": "8:00 am",
          "source": "RNS",
          "content": "28 Jan 2026 08:00\nRNS Number : 5671Q\nAIM\n28 January 2026\nNOTICE\n28/01/2026 - 08:00\nNOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM\nFollowing a Reverse Takeover the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.\nOVOCA BIO PLC\n213800ST2AK5XQ1O5207\nORDINARY SHARES OF EUR0.125 EACH, FULLY PAID (CDI)\n(B5641B8)(IE00B4XVDC01)\nOVCA/SHS VTG FPD EUR0.125\nIf you have any queries or require further information, please contact the company's nominated adviser.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAMOBRMBTMTMTBRF",
          "rns_number": "RNS Number : 5671Q"
        },
        {
          "title": "First Day of Dealings on AIM",
          "announcement_date": "28th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "28 Jan 2026 07:00\nRNS Number : 6015Q\nOvoca Bio PLC\n28 January 2026\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n7.00am 28 January 2026\nOvoca Bio plc\n{to be renamed\u00a0Talisman Metals PLC}\n(\"Talisman\" or the \"Company\")\nCompletion of acquisition of Tadeen International Limited\nand\nEnlarged Group admitted to trading on AIM\nOvoca Bio plc\n(to be renamed Talisman Metals PLC)\nannounces that following completion of the Reverse Takeover of Tadeen International Limited, Admission of its Enlarged Share Capital of 64,174,918 ordinary shares of \u20ac0.02 each (\"Ordinary Shares\") at an issue price of 7.7 pence each (\"Issue Price\") to trading on the London Stock Exchange's AIM (\"Admission\") is expected at 8:00am today.\nTherefore, the total number of voting rights is 64,174,918 and this figure may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.\nThe Company will change its name to Talisman Metals PLC once processed by the Irish Companies Registration Office, which it expects to become effective shortly. Additionally, immediately following the name change, the Company's TIDM will also change to \"TLM\". Given the expected change in the Company's name becoming effective shortly, the Company has updated its website address to\nwww.talismanmetalsplc.com\nwith effect from today. A further announcement will be made once the change of name is complete.\nHighlights\n\u00b7\nThe Company completed a fundraising to raise a gross amount of \u00a31,155,000 (the \"Fundraise\"), comprising a placing raising \u00a3350,000, and a subscription raising \u00a3805,000. This will be aggregated with the Company's existing cash resources, resulting in total cash resources of approximately \u00a32.255 million.\n\u00b7\nThe Fundraise was conducted to fund, along with its existing cash resources, the work programme on its core exploration permits at the Tizert and Argana projects, provide general working capital and fund the costs of Admission.\n\u00b7\nThe Company's market capitalisation on Admission will be approximately \u00a34.9 million.\n\u00b7\nTalisman is committed to the exploration and development of multiple copper deposits across the Atlas Mountains in Morocco.\n\u00b7\nThe Company is focused on its\u00a0Tizert and\u00a0Argana projects, where it holds five exploration permits for each project, with a total combined area of 129.8km2.\n\u00b7\nThe Tizert Project includes three target areas, the Fougnar, Tizert South and Tizert North permits, which are located are between 8km and 30km from the large Tizert Copper-Silver Project being developed by Managem SA Group (Managem), the Moroccan-listed Mining Group.\n\u00b7\nFougnar and the wider Tizert Project will form the core focus of the Company's immediate exploration strategy and expenditure.\n\u00b7\nThe existing Chief Executive Officer of Ovoca, Timothy McCutcheon, will serve as Chief Executive Officer of Talisman Metals.\n\u00b7\nTalisman's management team has a proven track record of successful discoveries, a strong commitment to responsible exploration, and extensive expertise in advancing projects from discovery to production.\nUse of Proceeds\nThe Company has raised \u00a31.155 million through the Fundraise. Following Admission, the gross proceeds will be aggregated with the Company's existing cash resources of approximately \u00a31.155 million, resulting in total cash resources available to the Company of approximately \u00a32.255 million.\nThe total cash on Admission is expected to be used to as follows:\n\u00b7\nTo settle outstanding Admission expenses of approximately \u00a3310,000;\n\u00b7\nTo fund the Phase 1 Exploration Programme amounting to \u00a3322,000;\n\u00b7\nTo fund approximately 75% of Phase 2 Exploration Expenditure of approximately \u00a3400,000; and\n\u00b7\nGeneral Working Capital purposes of approximately \u00a31,200,000.\nTimothy McCutcheon, CEO of Talisman Metals, said:\n\"\nToday marks an important milestone for Talisman, and I would like to thank our employees, shareholders, counterparties, and the many advisers who have worked tirelessly to complete the reverse takeover and achieve readmission to AIM. With the commencement of trading, the business is well positioned to move forward with a clear strategic focus, to further develop the potential of our exciting project portfolio.\n\"\nTalisman Metals - Overview\nTizert\n\u00b7\nThe Tizert Project includes the Fougnar, Tizert South and Tizert North permits, located between 8km and 30km from Managem's noteworthy Tizert Deposit.\no\nThe Tizert Deposit lies approximately 8km southwest of the Tizert North permits and is considered potentially on trend, although target depths exceed 300 metres (\"m\").\n\u00b7\nThe Company is targeting copper silver (\"Cu-Ag\") deposits of the Sediment-Hosted Stratiform Copper (SHSC) type, the world's second most important copper deposit type.\n\u00b7\nRecent geological mapping, rock chip and channel sampling completed at Fougnar and Tizert South returned copper grades of 0.50% to 1.44% Cu over 0.5m to 1.3m intervals.\n\u00b7\nA single drill hole completed at Tizert South in July 2025 intersected a minor copper bearing interval of 2m at an average of 0.27% Cu (Ag <1.5 grammes per tonne (\"g/t\")) from a depth of 99m, interpreted as the down-dip extension of surface mineralisation; Quality Control-Quality Assurance (QA-QC) results suggest grades may be slightly understated and may be approximately 0.30% Cu.\n\u00b7\nTwo drill holes at Tizert North were completed but require deepening to reach the target Basal Series.\n\u00b7\nNo drilling has yet been completed at Fougnar, which is considered the most prospective permit within the Tizert Project.\n\u00b7\nFougnar and the wider Tizert Project will form the core focus of the Company's immediate exploration strategy and expenditure.\nArgana\n\u00b7\nThe mineralisation type is of the red-bed copper which is a smaller subtype of the Sediment Hosted Copper type. Sporadic uranium mineralisation is observed at surface but the potential for more significant mineralisation of the sandstone-hosted type should be considered, as the geological setting is favourable.\n\u00b7\nRock chip and channel sampling confirmed high-grade copper mineralisation on adjacent excluded licence areas, returning values of up to 4.75% Cu and 50 g/t Ag, validating the regional mineralising system.\n\u00b7\nIn the project area, some lower grade copper mineralisation has been identified, including a channel sample returning 0.88% Cu over 1.0 m (true thickness).\n\u00b7\nA surface electrical survey completed in June 2025 identified several chargeability anomalies, that may or may not indicate sulphide mineralisation; some anomalies were observed but these may be due to clay layers or groundwater.\n\u00b7\nNo drilling has been undertaken at the Argana Project to date.\nMorocco Overview\n\u00b7\nMorocco is a relatively new jurisdiction for mineral exploration and development, with world-class geological potential.\n\u00b7\nThe new mining code, introduced in 2016, established a simplified, modern licensing framework.\n\u00b7\nIt has excellent infrastructure with ports, road and rail networks, and a reliable power supply.\n\u00b7\nMorocco has free-trade agreements in place with both the EU and the USA, and is increasingly integrated into global supply chains.\nBeaumont Cornish Limited is the Nominated Adviser and CMC Markets UK plc is acting as Sole Broker to the Company.\nDirector Share Subscription and Options\nTimothy McCutcheon, the Company's CEO and Executive Director, participated in the Subscription Shares for 177,546 shares, bringing his total ownership in the Company to 6,679,613, representing 10.4% of the Company's share capital.\nUpon readmission, the Company will issue a total of 3,100,000 options to directors, officers and advisors exercisable at \u00a30.077 valid for three years.\nAdmission Document\nThe Admission Document, which contains further information concerning the Company, is available to download from the Company's new website at:\nwww.talismanmetalsplc.com\n, where the AIM Rule 26 information on the Company is also available.\nCapitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Admission Document.\nEnquiries:\nOvoca Bio plc\nTimothy\u00a0McCutcheon, CEO\ninfo@ovocabio.com\nTel: +353 (0) 1 525 6710\nNominated Adviser\nBeaumont Cornish Limited\nRoland Cornish\nJames Biddle\nTel: +44 (0) 20 7628 3396\nBroker\nCMC Markets UK plc\nThomas Smith / Thomas Curran\nTel: +44 (0) 20 3003 8255\nFinancial PR\nBlytheRay PR\nSaid Izagaren / James Mulligan / Matt Bowld\nTel: +44 (0) 20 7138 3204\ntalismanmetals@blytheray.com\nNotes to Editors\nTalisman Metals is committed to the exploration and development of multiple copper deposits across its Tizert and Argana projects, located in Morocco. Leveraging both advanced geological analysis and the latest exploration technologies, the Company's expert team is dedicated to unlocking the region's vast mineral potential. With a focus on sustainability and innovation, Talisman aims to bring new, high-quality sources of copper to meet growing global demand and support the transition to a greener, electrified future.\nBeaumont Cornish, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company as Nomad in connection with the Admission and is not acting for any other person (including a recipient of this document) or otherwise be responsible to any person for providing the protections afforded to clients of Beaumont Cornish or for advising any other person in respect of the Admission or any transaction, matter or arrangement referred to in this document. The responsibility of Beaumont Cornish, as the Nomad, under the AIM Rules for Nominated Advisers is owed solely to the London Stock Exchange and is not owed to the Company or the Directors or any other person.\nCMC Markets UK plc (\"CMC\") or (the \"Broker\"), which are authorised and regulated in the United Kingdom by the Financial Conduct Authority, are acting as sole broker to the Company in connection with the proposed re-admission of the Enlarged Share Capital to trading on AIM and the Placing. The Broker is acting exclusively for the Company and for no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or the Placing or the proposed re-admission of the Enlarged Share Capital to trading on AIM.\nNo representation or warranty, express or implied, is made by Beaumont Cornish, Broker or any of their respective Representatives as to the contents of this document (without limiting the statutory rights of any person to whom this document is issued). No liability whatsoever is accepted by Beaumont Cornish, Broker or any of respective Representatives for the accuracy of any information or opinions contained in this document or for the omission of any material information for which it is not responsible. The information contained in this document is not intended to inform or be relied upon by any subsequent purchasers of Ordinary Shares (whether on or off exchange) and accordingly, to the extent permitted by law, no duty of care is accepted by the Company, Beaumont Cornish or Broker in relation to any of them.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCUBSVRNBUAUAR",
          "rns_number": "RNS Number : 6015Q"
        },
        {
          "title": "Result of Meeting",
          "announcement_date": "27th Jan 2026",
          "release_time": "2:32 pm",
          "source": "RNS",
          "content": "27 Jan 2026 14:32\nRNS Number : 5952Q\nOvoca Bio PLC\n27 January 2026\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n27 January 2026\nOvoca Bio plc\n{to be renamed\u00a0Talisman Metals PLC}\n(\"Talisman\" or the \"Company\")\nResult of General Meeting\nCompletion of Share Capital Reorganisation\nIssue of New Ordinary Shares\nResult of AGM\nOvoca Bio plc\n(to be renamed Talisman Metals PLC)\nis pleased to provide the results of the General Meeting held earlier today in connection with the acquisition of Tadeen International Limited and other matters (the \"Transaction\"). All resolutions were passed and accordingly completion of the Acquisition will proceed along with issue of the New Ordinary Shares of \u20ac0.02 each (the \"New Ordinary Shares\"), the Consideration Shares and Fundraising Shares.\nResult of General Meeting\nAt the General Meeting held today at 11am, all resolutions were passed on a show of hands.\nA copy of the Notice of General Meeting, contained in the Admission Document, is available on the Company's website,\nhttps://ovocabio.com\n.\nAs previously announced on 31 December 2025, completion of the Acquisition and Admission of the Enlarged Share Capital to trading on AIM is expected to commence on 28 January 2026 at 8:00am. The ISIN for the New Ordinary Shares is IE000XRZAWV1 and SEDOL is BV5DLB8.\nCapitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Admission Document.\nResult of AGM\nFurthermore, the Company has also held its AGM today and all resolutions proposed at the AGM were passed. A copy of the Notice of AGM is available on the Company's website.\nEnquiries:\nOvoca Bio plc\nTimothy\u00a0McCutcheon, CEO\ninfo@ovocabio.com\nTel: +353 (0) 1 525 6710\nNominated Adviser\nBeaumont Cornish Limited\nRoland Cornish\nJames Biddle\nTel: +44 (0) 20 7628 3396\nBroker\nCMC Markets UK plc\nThomas Smith / Thomas Curran\nTel: +44 (0) 20 3003 8255\nFinancial PR\nBlytheRay PR\nSaid Izagaren / James Mulligan / Matt Bowld\nTel: +44 (0) 20 7138 3204\ntalismanmetals@blytheray.com\nBeaumont Cornish, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company as Nomad in connection with the Admission and is not acting for any other person (including a recipient of this document) or otherwise be responsible to any person for providing the protections afforded to clients of Beaumont Cornish or for advising any other person in respect of the Admission or any transaction, matter or arrangement referred to in this document. The responsibility of Beaumont Cornish, as the Nomad, under the AIM Rules for Nominated Advisers is owed solely to the London Stock Exchange and is not owed to the Company or the Directors or any other person.\nCMC Markets UK plc (\"CMC\") or (the \"Broker\"), which are authorised and regulated in the United Kingdom by the Financial Conduct Authority, are acting as sole broker to the Company in connection with the proposed re-admission of the Enlarged Share Capital to trading on AIM and the Placing. The Broker is acting exclusively for the Company and for no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or the Placing or the proposed re-admission of the Enlarged Share Capital to trading on AIM.\nNo representation or warranty, express or implied, is made by Beaumont Cornish, Broker or any of their respective Representatives as to the contents of this document (without limiting the statutory rights of any person to whom this document is issued). No liability whatsoever is accepted by Beaumont Cornish, Broker or any of respective Representatives for the accuracy of any information or opinions contained in this document or for the omission of any material information for which it is not responsible. The information contained in this document is not intended to inform or be relied upon by any subsequent purchasers of Ordinary Shares (whether on or off exchange) and accordingly, to the extent permitted by law, no duty of care is accepted by the Company, Beaumont Cornish or Broker in relation to any of them.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nROMBRMITMTTTBPF",
          "rns_number": "RNS Number : 5952Q"
        },
        {
          "title": "Schedule One - Ovoca Bio Plc",
          "announcement_date": "31st Dec 2025",
          "release_time": "8:00 am",
          "source": "RNS",
          "content": "31 Dec 2025 08:00\nRNS Number : 2768N\nAIM\n31 December 2025\nANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES (\"AIM RULES\")\nCOMPANY NAME:\nOvoca Bio Plc (\"Ovoca\") to be renamed\nTalisman Metals plc\non Admission (\"Talisman\" or the \"Company\")\nCOMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):\n17 Pembroke Street Upper\nDublin 2\nD02 AT22\nIreland\nCOUNTRY OF INCORPORATION:\nIreland\nCOMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:\nhttps://www.ovocabioplc.com\nto be\nwww.talismanmetalsplc.com\nafter re-Admission\nCOMPANY BUSINESS (INCLUDING\nMAIN COUNTRY OF OPERATION\n) OR, IN THE CASE OF AN\nINVESTING COMPANY\n, DETAILS OF ITS\nINVESTING POLICY\n). IF THE\nADMISSION\nIS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:\nOn 7 May 2025, Ovoca announced it had entered into a conditional Letter of Intent (\"\nLOI\n\") to acquire 100% of Tadeen, a UK-registered company, which indirectly owns 100% of the Licences in Morocco, prospective for Copper and Silver (the \"\nAcquisition\n\"), through its wholly owned subsidiary, Horizons Mines SARL.\nTadeen was incorporated in 2021 and since that time has sought to develop and subsequently commercialise mineral exploration and exploitation properties with strong geological potential in the promising jurisdiction of Morocco. The Company will only focus its work on 10 of the exploration permits, five comprising the\nTizert Project\nand five making up the\nArgana Project\n, with a total combined area of 129.8km2 (together the \"\nExploration Permits\n\" for the purposes of this Document). These are between 8 and 30km from the large Tizert Copper-Silver Project being developed by the Managem SA Group (Managem) the Moroccan listed Mining Group for which the Government owns a majority stake. On completion of the Transaction, various members of the senior management team of Tadeen will be integrated into the Enlarged Group. The existing Chief Executive Officer of Ovoca, Timothy McCutcheon, will serve as Chief Executive Officer of the Enlarged Group.\nThe Transaction constitutes a reverse takeover under AIM Rule 14, requiring the approval of a majority of the Shareholders voting in person or by proxy at a general meeting\nOn Admission, Talisman Metals plc will, through its wholly owned Bermudan subsidiary T Metals Limited, will own 100% of Tadeen (the acquisition target) which in turn holds 100% of Horizons Mines SARL who own the Exploration Permits.\nDETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY\nRESTRICTIONS AS TO TRANSFER\nOF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):\nNumber of ordinary shares of \u20ac0.02 each (\"Ordinary Shares\") for which Admission is being sought: 64,174,918\nThe Ordinary Shares are and will remain freely transferable and have no restrictions as to transfer placed on them.\nThe issue price: 7.7 pence (the \"Issue Price\").\nNo Shares are or will be held in treasury.\nCAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:\nCapital to be raised on Admission: \u00a31.155 million\nAnticipated market capitalisation on Admission: approximately \u00a34.9 million (at the Issue Price)\nPERCENTAGE OF AIM SECURITIES\nNOT IN PUBLIC HANDS AT ADMISSION\n:\n39.01%\nDETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM\nTO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:\nN/A\nTHE COMPANY HAS APPLIED FOR THE\nVOLUNTARY CARBON MARKET DESIGNATION\n(Y/N)\nNo\nFULL NAMES AND FUNCTIONS OF\nDIRECTORS\nAND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):\nTimothy (\"\nTim\n\") Rand McCutcheon - Chief Executive Officer\nLeah\nEllen O'Donovan - Chief Financial Officer\nJonathan\nGeorge Henry - Independent Non-Executive Chair\nAnastasia\nLevashova - Independent Non-Executive Director\nThomas (\"T\nom\n\") Alan Garagan - Independent Non-Executive Director\nDr\nMohammed\nMouhib - Non-Executive Director\nFULL NAMES AND HOLDINGS OF\nSIGNIFICANT SHAREHOLDERS\nEXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):\nName\nNumber of Ordinary Shares before Admission\nPercentage of\nExisting\nOrdinary Shares\nNumber of Ordinary Shares on Admission**\nPercentage\nof\nEnlarged\nShare\nCapital\nEuoclear Nominees Limited*\n67,913,860\n76.77%\n22,637,953\n35.28%\nTimothy McCutheon (CEO)*\n19,506,203\n22.05%\n6,679,613\n10.41%\nPicko Trading Co Limited\n10,002,077\n11.31%\n3,334,026\n5.20%\nNational Settlement Depository*\n9,893,214\n11.18%\n3,297,738\n5.14%\nInvestor Services Nominees Limited*\n4,158,532\n4.70%\n1,386,177\n2.16%\nCambrian Limited\n-\n-\n6,252,049\n9.74%\nCharterhouse Trustees Limited\n-\n-\n6,252,049\n9.74%\nAya Silver & Gold Inc.\n-\n-\n3,000,000\n4.67%\nZakariae Mouhib\n-\n-\n2,925,610\n4.56%\nMohamed Baoutoul\n-\n-\n2,925,610\n4.56%\n* All of these shares are held through Euroclear Nominees Limited\n** Following a 3:1 share consolidation\nNAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:\nNone\n(i) ANTICIPATED ACCOUNTING REFERENCE DATE\n(ii) DATE TO WHICH THE\nMAIN FINANCIAL INFORMATION\nIN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)\n(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:\n(i) 31 December\n(ii) 30 June 2025\n(iii) As follows:\n-\n30 June 2026 (audited accounts for the year ended 31 December 2025)\n-\n30 September 2026 (unaudited interim financial statements for 6 months ended 30 June 2026)\n-\n30 June 2027 (audited accounts for the year ended 31 December 2026)\nEXPECTED ADMISSION DATE:\n28 January 2026\nNAME AND ADDRESS OF NOMINATED ADVISER:\nBeaumont Cornish Limited\n5-10 Bolton Street\nLondon\nW1J 8BA\nNAME AND ADDRESS OF BROKER:\nCMC Markets UK plc\n133 Houndsditch\nLondon\nEC3A 7BX\nOTHER THAN IN THE CASE OF A\nQUOTED APPLICANT\n, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:\nThe AIM Admission Document, which will contain full details of the applicant and admission of its securities, will be available from the Company's website:\nhttps://www.ovocabioplc.com\nto be\nwww.talismanmetalsplc.com\nafter re-Admission\nTHE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY\nQCA Code\nDATE OF NOTIFICATION:\n31 December 2025\nNEW/ UPDATE:\nNew\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nPAAPKDBPABDKBBN",
          "rns_number": "RNS Number : 2768N"
        }
      ],
      "themes": [
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 713,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "ACCUMULATION"
    },
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2025-01-13"
    }
  },
  "ai_insights": {
    "company_30s": {
      "what_they_do": "Ovoca Bio PLC is a UK\u2011based biotechnology company that develops and commercialises therapeutic products for unmet medical needs.",
      "why_they_matter": "The biotech sector offers high\u2011growth opportunities, especially for novel treatments that can address rare or chronic diseases.",
      "current_state": "The company is still in early development, has just completed its first day of trading on AIM, and is in a pre\u2011revenue stage. It has recently re\u2011branded and filed a series of routine corporate announcements."
    },
    "whats_happening_now": {
      "rns_narrative": [
        "The company has just re\u2011entered the market, changed its name, and finished its first trading day on AIM \u2013 all signalling a fresh start.",
        "Recent filings are routine corporate notices (AGM, meeting results, admission documents) rather than substantive product or financial news.",
        "No new clinical data, partnership, or funding round has been announced, so the bottom\u2011bouncing narrative is still missing."
      ],
      "crowd_tape": {
        "dominant_theme": "Radio silence \u2013 no chatter on social or mainstream media.",
        "bull_narrative": "No bullish signals or positive commentary have emerged.",
        "bear_narrative": "No bearish warnings either \u2013 simply a lack of information.",
        "sentiment_shift": "The sentiment remains flat; there is no visible shift toward optimism or pessimism."
      },
      "attention_check": "Google Trends is flat, indicating no public interest and a high potential for a surprise catalyst if one appears."
    },
    "expect_next": {
      "near_term_catalysts": [
        "A major clinical milestone (e.g., first\u2011in\u2011human data or phase 2 results) could act as a trigger.",
        "A partnership or licensing agreement with a larger pharma company would signal credibility.",
        "A successful funding round or new investor announcement could provide the cash needed for product development."
      ],
      "watch_for": "Look for a sudden increase in trading volume, a sharp price move on a daily close, or any press release that mentions clinical progress or a new partnership.",
      "timing_regime": "The stock is still in the early pre\u2011clinical stage \u2013 there is no clear bottom yet and the market is waiting for a catalyst."
    },
    "buy_vs_sell": {
      "lean": "Neutral \u2013 lean bearish until a clear catalyst emerges.",
      "bull_case": "If a clinical breakthrough or partnership is announced, the stock could jump sharply because the market will finally recognise value. Historically, deep\u2011crash stocks can rebound 50\u2011100% once a catalyst hits.",
      "bear_case": "Without any tangible progress, the stock could continue to drift down, especially if investors remain uncertain about the product pipeline.",
      "risk_reward": "Risk is high (potential further decline) and reward is uncertain \u2013 the asymmetry is not favourable at this stage."
    },
    "playbook": {
      "if_bullish": "Only enter if a concrete catalyst (clinical data or partnership) is announced. Start with a small position (10\u201115% of allocated capital) and use a tight stop just below the recent low.",
      "if_watching": "Hold cash until a clear news event or a technical signal (volume spike, break above a key support) appears. Do not trade on speculation alone.",
      "if_passing": "Skip this security for now. The lack of data and no visible bottom make it a poor contrarian candidate."
    },
    "bottom_line": "Ovoca Bio is a very early\u2011stage biotech with no catalyst yet \u2013 keep it off the radar until a clear clinical or partnership announcement surfaces.",
    "_selected_rns": [
      {
        "title": "Readmission - Ovoca Bio PLC",
        "date": "2026-01-28T00:00:00",
        "importance_score": 0.7866416978776529,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Change of Name",
        "date": "2026-02-05T00:00:00",
        "importance_score": 0.7106741573033708,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "First Day of Dealings on AIM",
        "date": "2026-01-28T00:00:00",
        "importance_score": 0.6477528089887641,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Result of Meeting",
        "date": "2026-01-27T00:00:00",
        "importance_score": 0.6398876404494382,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Notice of AGM",
        "date": "2025-12-31T00:00:00",
        "importance_score": 0.5664169787765293,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Publication of Admission Document",
        "date": "2025-12-31T00:00:00",
        "importance_score": 0.5664169787765293,
        "time_bucket": "MID",
        "rns_number": ""
      }
    ]
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [
        "FDA/EMA rejection or delay"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 70.0,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 40.0,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 40/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 9900% proven capacity",
        "\ud83d\udcb0 Deep value: 28% off recent peak"
      ],
      "verdict": "\u2705 Facts align with low fear - Normal risk/reward"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 70/100",
        "color": "#f59e0b"
      },
      {
        "type": "BROKEN",
        "icon": "\u274c",
        "text": "Broken",
        "color": "#ef4444"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 58",
        "color": "#3b82f6"
      },
      {
        "type": "LOW_DATA",
        "icon": "\u2753",
        "text": "Conf 25",
        "color": "#64748b"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Change of Name",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Readmission - Ovoca Bio PLC",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "First Day of Dealings on AIM",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Result of Meeting",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Schedule One - Ovoca Bio Plc",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c AVOID - timing BROKEN",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "70/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "BROKEN",
          "pass": false,
          "icon": "\u274c"
        },
        {
          "criterion": "APEX Quality",
          "value": "58/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "25/100",
          "pass": false,
          "icon": "\u2753"
        },
        {
          "criterion": "Industry Pattern",
          "value": "1 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "3/5"
    },
    "contrarian_panic": {
      "total_score": 47,
      "band": "\ud83d\udfe1 MODERATE COMPRESSION (Top 30% - GOOD SETUP)",
      "components": {
        "compression": {
          "score": 7,
          "max": 40,
          "signals_30d": 1,
          "signals_60d": 1,
          "signals_90d": 1,
          "signals_per_week": 0.08,
          "total_signals": 24,
          "rsi_extreme_count": 1,
          "rsi_ultra_count": 1,
          "escalation_count": 0,
          "density_score": 3,
          "rsi_score": 4,
          "escalation_score": 0,
          "description": "0.1 signals/week | 1 RSI<20 | Early stage"
        },
        "intensification": {
          "score": 20,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "EXTREME CRASH BOTTOM",
            "ULTRA CRASH BOTTOM"
          ],
          "escalating": true,
          "sustained": false,
          "current_intensity": 4,
          "pattern": "ESCALATING TO EXTREME - Fear building!"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.94,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 15,
          "max": 15,
          "best_historical_rally": 9900.0,
          "avg_rally": 509.9,
          "signal_count": 24,
          "description": "MONSTER POPPER - Historical 10x+ (9900%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation detected"
        }
      },
      "ticker": "OVB.L",
      "signal_date": "2025-01-10",
      "total_signals_history": 24
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +18 (AI_Technical_Score=14.0/20)",
      "Drawdown reversion potential: +20 (Drawdown_Pct=99.2%)",
      "Volume confirmation: +10 (Relative_Volume=2.9)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +20 (best_rally_pct=9900%)",
      "Split risk penalty: -15 (HIGH, age_factor=1.00)"
    ],
    "technical_score": {
      "points": 18,
      "ai_score": 14.0,
      "reason": "AI Technical Score 14.0/20 translates to 18/25 points"
    },
    "drawdown_score": {
      "points": 20,
      "drawdown_pct": 99.19,
      "reason": "Drawdown of 99.2% gives 20/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.94,
      "reason": "Relative volume 2.94x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 20,
      "best_rally_pct": 9900.0,
      "reason": "Best rally of 9900% gives 20/20 points"
    },
    "penalties": {
      "total": -15,
      "items": [
        "Split risk penalty: -15 (HIGH, age_factor=1.00)"
      ]
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Historically strong runner - massive upside when it moves",
        "tag": "HIGH",
        "evidence": [
          "best_rally_pct=9900%",
          "Rally_Count=1.0"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Split risk HIGH - price integrity compromised",
        "tag": "HIGH",
        "evidence": [
          "split_risk_level=HIGH"
        ]
      },
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-01-10"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Avoid",
      "action": "Do not trade - thesis invalidated",
      "sizing": "0%",
      "risk": "N/A",
      "profit_taking": "N/A"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "BROKEN",
    "run_multiple": -0.0,
    "current_run_pct": -28.12,
    "avg_historical_run_pct": 9900.0
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows BROKEN timing with 58/100 APEX score. Historical data shows 1 rallies averaging 9900% upside. Current position: -28.1%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Strong historical rally behavior (9900% best run)"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Thesis invalidated. Avoid or exit.",
    "confidence_explained": "Confidence 25/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}